Fifth disease - Faama'I Lona Lima
☆ I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
16-masina le matua ma Faama'I Lona Lima (Fifth disease) ― E mumu uma alafau, e pei o le po, ma aliali mai maculopapular mageso i luga o le tino.
Erythema i alafau uma e lua.
References
Fifth disease , e ta'ua fo'i o le erythema infectiosum, ose fa'ama'i viral e mafua mai ile parvovirus ole tagata B19. E sili atu ona taatele i tamaiti, e masani ona aafia ai i latou i le va o le 4 i le 14 tausaga. E masani ona amata auga ile fiva vaivai, ulu tiga, fa'a'i tiga, ma lagona pei ole fulū. E mafai e tamaiti ona atia'e se mageso mumu manino i luga o foliga e pei o le slapped cheeks , fa'atasi ai ma se mageso mamanu i luga o le tino, lima, ma vae. I tagata matutua, o le tiga o sooga o se faʻasea masani, lea e ono aliali mai i vaiaso pe a maeʻa le faʻamaʻi muamua. Ae maise, pe a ma le 20 i le 30% o tagata matutua ua a'afia ile parvovirus B19 atonu e le fa'aalia ni fa'ailoga.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
O le lamatiaga o le pasi atu o le parvovirus B19 mai le tina i le pepe e tusa ma le 33%, ma e tusa ma le 3% o fafine ua aafia o loʻo feagai ma faʻalavelave ia latou pepe. Pe a pisia le tina a o lei atoa le 20 vaiaso o le maitaga, e faatupulaia le avanoa e tulai mai ai ni faaletonu e pei o le toto ma le faaputuputuina o le suavai i le tino o le pepe. Ina ia amata pulea lenei faʻamaʻi, e tatau ona tatou siaki pe na faʻaalia le tagata maʻi i le parvovirus e ala i le suʻega mo ni faʻamaʻi (IgM) . Afai o le suʻega e leʻi faʻaalia i se taimi ua tuanaʻi ae faʻaalia se faʻamaʻi lata mai, e manaʻomia e le tagata maʻi le mataʻituina lelei i le taimi o le maitaga, e aofia ai suʻesuʻega masani ole ultrasound e siaki ai ni faʻafitauli o le soifua maloloina o pepe.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
faama'i lona lima (fifth disease) e amata ile fiva maualalo, ulu tiga, mageso, ma fa'ailoga e pei ole malulu, e pei ole susu pe susu. O nei fa'ailoga e pasi, ona mavae ai lea o ni nai aso, e aliali mai le mageso. O le mageso mumu mumu e masani ona aliali mai i foliga, aemaise o alafau. (o le mea lea o le igoa "faʻamaʻi alafau sasa"). I le faaopoopo atu i alafau mumu, e masani ona atiaʻe e tamaiti se mumu, mageso i luga o le tino atoa, ma o lima pito i luga, tino, ma vae o nofoaga sili ona taatele.
O le ma'i e masani lava ona vaivai, ae i fafine ma'itaga, o fa'ama'i i le masina muamua e feso'ota'i ma le hydrops fetalis, ma mafua ai ona fa'ato'i fa'ato'i fanau.
○ Togafiti
Leai se togafitiga faʻapitoa e manaʻomia ona e masani ona faʻaleleia i le taimi.